论文部分内容阅读
近年来,随着人类基因组测序工作进展顺利,分子诊断学也由此获得了迅速发展并已有一些产品实际用于疾病筛分、诊断和治疗监测。据估计,现在美国有约300多家公司活跃在分子诊断学领域,这些公司正在应用它们的专有技术积极从事着药物发现和发展及疾病临床诊断应用研究。1.诊断学和分子诊断学借助来自基因组
In recent years, with the progress of human genome sequencing, molecular diagnostics has also gained rapid development and some products have been actually used in disease screening, diagnosis and treatment monitoring. It is estimated that more than 300 companies in the United States are now active in molecular diagnostics. These companies are using their proprietary technology to actively engage in drug discovery and development and clinical diagnostic applications of the disease. 1. Diagnostics and molecular diagnostics come from the genome